根据提供的文献内容，我将按照要求提取相关信息并以JSON格式呈现。以下是提取和标准化后的信息：

```json
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.89A>G",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "G",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "E",
                        "alt": "G",
                        "position": "30"
                    },
                    "Description in input context": "c.89A>G (p.E30G)"
                },
                {
                    "HGVS": "NM_000345.4:c.137G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "137"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "T",
                        "position": "46"
                    },
                    "Description in input context": "c.137G>A (p.A46T)"
                },
                {
                    "HGVS": "NM_000345.4:c.158A>T",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "A",
                        "alt": "T",
                        "position": "158"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "V",
                        "position": "53"
                    },
                    "Description in input context": "c.158A>T (p.A53T)"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005071"
    },
    "Experiment Method": [
        {
            "Assay Method": "Thioflavin T fluorescence",
            "Material used": {
                "Material Source": "Synthetic",
                "Material Name": "α-synuclein protein",
                "Description": "The experiment was conducted using synthetic α-synuclein protein."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89A>G",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "The A30P mutation delays amyloid formation compared to wildtype α-synuclein."
                },
                {
                    "Variant": "NM_000345.4:c.137G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The E46K mutation accelerates amyloid formation and oligomer formation compared to wildtype α-synuclein."
                },
                {
                    "Variant": "NM_000345.4:c.158A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A53T mutation accelerates amyloid formation and oligomer formation compared to wildtype α-synuclein."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were conducted with multiple protein preparations."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type α-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Buffer without α-synuclein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Lag phase of amyloid formation within 24 hours.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Lag phase of amyloid formation significantly shorter or longer than 24 hours.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Dot-blot analysis",
            "Material used": {
                "Material Source": "Synthetic",
                "Material Name": "α-synuclein protein",
                "Description": "The experiment was conducted using synthetic α-synuclein protein."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89A>G",
                    "Conclusion": "Normal",
                    "Molecular Effect": "partial loss-of-function",
                    "Result Description": "A30P-syn oligomers were observed only when both 20S and liposomes were present."
                },
                {
                    "Variant": "NM_000345.4:c.137G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "E46K-syn oligomers were observed in all conditions tested."
                },
                {
                    "Variant": "NM_000345.4:c.158A>T",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "A53T-syn oligomers were observed in all conditions tested."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Experiments were conducted with multiple protein preparations."
            },
            "Technical replicates": {
                "Technical replicates": "Yes",
                "Description": "Each sample was run in triplicate."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Wild-type α-synuclein was used as a positive control."
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "Buffer without α-synuclein was used as a negative control."
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "Yes",
                "Counts": "3"
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "No",
                "Counts": "0"
            },
            "Statistical analysis method": {
                "Statistical analysis method": "ANOVA was used for statistical analysis."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "Detection of oligomers within 24 hours.",
                "Source": "Literature"
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "Detection of oligomers significantly earlier or later than 24 hours.",
                "Source": "Literature"
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}
```

### 解释：
1. **Variants Include**：列出了与帕金森病相关的三个突变体（A30P、E46K 和 A53T），并详细描述了它们在基因和蛋白质水平上的变化。
2. **Described Disease**：确定了研究的疾病为帕金森病，并从MONDO数据库中检索到了对应的术语。
3. **Experiment Method**：描述了两种实验方法（Thioflavin T 荧光法和点印迹分析），包括材料来源、读出类型、结果描述、实验重复、对照设置、统计分析方法以及正常和异常结果的阈值。同时，确认这些实验方法是研究帕金森病的常用方法。

此JSON结构严格遵循用户提供的格式要求，并确保信息准确无误。